Table of Content
Chair's Introduction ( Shomi S Battacharya ). Gene therapy of retinal dystrophies: Achievements, challenges and prospects ( Dean Bok ). Identifying retinal disease genes: how far have we come, how far do we have to go? ( Stephen P Daiger ). Dominant cone and cone-rod dystrophies: functional analysis of mutations in regGC1 and GCAP1 ( David Hunt, Susan E Wilkie, Richard Newbold, Evelyne Deery, Martin J Warren, Shomi S Battacharya, and Kang Zhang ). Isotretinoin treatment inhibits lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration ( Roxana A Radu, Nathan L Mata, Steven Nusinowitz, Xinran Liu, and Gabriel H Travis ). The expanding roles of ABCA4 and CRB1 in inherited blindness ( F P M Cremers, A Maugeri, A I den Hollander, and C B Hoyng ). What should a clinician know to be prepared for the advent of treatment of retinal dystrophies? ( Alan C Bird ). Role of subunit assembly in autosomal dominant retinitis pigmentosa link ed to mutations in perpherin 2 ( Robert S Molday, Laurie L Molday, and Christopher J R Loewen ). The search for rod-dependent cone viability factors, secretedd factors promoting cone viability ( Thierry Leveillard, Saddek Mohand-Said, Anne-Claire Fintz, George Lambrou, and Jose-Alain Sahel ). Studies on retinal and retinal pigment epithelial gene expression ( Itay Chowers, Noriko Esumi, Peter Campochiaro, and Donald J Zack ). From disease genes to cellular pathways: a progress report ( J Yu, A J Mears, S Yoshida, R Farjo, T A Carter, D Ghosh, A Hero, C Barlow, and A Swaroop ). Prospects for gene therapy ( Robin R Ali ). Range of retinal diseases potentially treatable by AAV-vectored gene therapy (William S Hauswirth, Quihong Li, Brian Raisler, Adrian M Timmers, Kenneth I Berns, John G Flannery, Matthew M LaVail, and Alfred S Lewin). Gene therapy for Leber congenital amaurosis ( Jean Bennett ). Index of Contributors. Subject Index.
